COVID and client work has kept me way too busy this week – hope to be back to more frequent posting soon. Meanwhile, here’s what I missed…
Workers’ comp drug trends
myMatrixx released its annual Drug Trends Report. Key findings include:
- 6.1% drop in drug spend for myMatrixx clients
- 10.7% drop in opioid spend
- over five years, clients’ opioid spend dropped 45%
- Lyrica’s brand patent expired; within 4 weeks over 90% of patients had been switched to a less-costly generic
(myMatrixx is an HSA consulting client)
Workers’ comp pharmacy regulations – WCRI’s national inventory
Is available for purchase here. This is a must-have for any and all workers’ comp payers. Info on medical marijuana, opioid prescribing limits, drug testing, and pricing is all there.
Presumption
Pretty solid summary of presumption changes provided by the Premium Reduction blog; some good reporting on numbers of claims in FL, CO and CA as well.
Medical pricing lookup
Medata has a pretty cool medical service pricing lookup tool that’s useful for consumers, adjusters, and employers. It includes pricing for group health, auto, and workers’ comp.
COVID’s impact
Thanks to Risk & Insurance’s Courtney DuChene for her reporting on our survey of COVID”s impact on workers’ comp.
Finally, this…
And, one day, perhaps this…
